The prognostic value of absolute lymphocyte count in patients with newly diagnosed adult primary immune thrombocytopenia
-
摘要: 目的:探讨淋巴细胞绝对值(ALC)对于成人新诊断的原发免疫性血小板减少症(ITP)患者预后的影响,为临床评估预后提供新的理论支持。方法:回顾性分析152例成人新诊断的ITP患者的临床及实验室检查结果等指标,总结其临床特点,探讨ALC对于疾病预后的影响,并分析影响患者预后的相关危险因素。结果:152例新诊断ITP患者的中位发病年龄50.5(27.0~63.0)岁;其中男62例,女90例,男∶女为0.69∶1.00。中位随访时间9.75(3.88~25.00)个月,复发24例(15.78%)。以疾病复发作为终点得到外周血ALC的受试者工作特征曲线,ALC的截点值为1.070×109/L,曲线下面积为0.604(95%CI 0.491~0.717)。以1.070×109/L为界,分为高ALC组和低ALC组,2组临床特征比较显示,高ALC组合并高血压患者比例明显高于低ALC组(P=0.006),其余方面比较差异无统计学意义(P＞0.05)。对于影响疾病复发的临床特征进行单因素分析及多因素Logistic回归分析发现,ALC＞1.070×109/L是影响新诊断的成人ITP复发的独立危险因素(P=0.004)。结论:对于新诊断的成人ITP患者,较高的淋巴细胞计数对于疾病复发有一定的预测作用,应引起重视。Abstract: Objective:To explore the influence of absolute lymphocyte count(ALC) on the prognosis of newly diagnosed primary immune thrombocytopenia(ITP) in adults,in order to provide more evidence for the treatment of it.Method:The clinical and laboratory examination results of 152 newly diagnosed adult ITP patients were retrospectively analyzed.The influence of ALC on the prognosis of the disease was discussed,and clinical features and prognostic factors of adult ITP were analyzed.Result:Among 152 newly diagnosed ITP patients,62 were male and 90 were female,and the ratio of male to female was 0.69∶1.00,with an median age was 50.5(27.0-63.0) years old.With a median follow-up of 9.75(3.88-25.00) months,there were 24 patients(15.78%) who finally relapsed.The receiver operating characteristics curve of peripheral blood ALC was obtained with the disease recurrence as the endpoint.The cut-off point value of ALC was 1.070×109/L,the area under the curve was 0.604(95%CI 0.491-0.717).Taking 1.070×109/L as the boundary,the group was divided into high ALC group and low ALC group.The comparison of clinical features between the two groups showed that patients with hypertension in the high ALC group was significantly higher than that in the low ALC group(P=0.006),and there were no statistically significant differences in other clinical features between two groups.Single factor analysis and multi factor Logistic regression analysis on the clinical characteristics of disease recurrence showed that ALC＞1.070×109/L was the independent risk factor of ITP recurrence in newly diagnosed adults(P=0.004).Conclusion:For newly diagnosed adult ITP patients,a higher lymphocyte count has a certain predictive effect on disease recurrence,which needs to be taken into account.
-
Key words:
- primary immune thrombocytopenia /
- absolute lymphocyte count /
- prognosis
-
-
[1] Rodeghiero F,Stasi R,Gernsheimer T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113:2386-2393.
[2] Cetin K,McGrath LJ,Overman R,et al.Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States[J].Blood,2019,132:497.
[3] Shuling L,Julia TM,Karynsa C,et al.Rate of Bleeding-Rated Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP):A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data[J].Blood,2015,126:38.
[4] 侯明,秦平.成人原发免疫性血小板减少症诊治的中国专家共识(2016版)解读[J].临床血液学杂志,2016,29(7):523-527.
[5] Lambert MP,Gernsheimer TB.Clinical updates in adult immune thrombocytopenia[J].Blood,2017,129:2829-2835.
[6] Korkmaz S,Uslu AU,Aydin B,et al.Pre-treatment and post-treatment changes in platelet indices in patients with immune thrombocytopenia[J].Saudi Med J,2013,34:591-596.
[7] 申星,程芳芳,常舒婷,等.外周血自然杀伤细胞比例在原发免疫性血小板减少症中临床意义[J].临床血液学杂志,2019,32:48-51.
[8] Kashiwagi H,Tomiyama Y.Pathophysiology and management of primary immune thrombocytopenia[J].Int J Hematol,2013,98:24-33.
[9] Olsson B,Andersson PO,Jernas M,et al.T-cel-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura[J].Nat Med,2003,9:1123-1124.
[10] Mckenzie CG,Guo L,Freedman J,et al.Cellular immune dysfunction in immune thrombocytopenia(ITP)[J].Br J Haematol,2013,163:10-23.
[11] Coussens LM,Werb Z.Inflammation and cancer[J].Nature,2002,420:860-867.
[12] Ray-Coquard I,Cropet C,Van Glabbeke M,et al.Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas[J].Cancer Res,2009,69:5358-5391.
[13] Huang JJ,Jiang WQ,Lin TY,et al.Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma,nasal type[J].Ann Oncol,2011,22:149-155.
[14] 王明镜,胡晓梅,邓中阳,等.免疫性血小板减少症的免疫机制研究进展[J].临床血液学杂志,2017,30(9):725-728.
-
计量
- 文章访问数: 172
- PDF下载数: 81
- 施引文献: 0
下载: